Outcomes with Sacubitril/Valsartan in Outpatients with Heart Failure and Reduced Ejection Fraction: The ARIADNE Registry — Aldo Maggioni (2022) | RDL Network
This large HFrEF European registry provides a contemporary outcome profile of outpatients with HFrEF treated with or without sacubitril/valsartan. In a real-world setting, sacubitril/valsartan was associated with an improvement of symptoms in patients with HFrEF compared with the conventional HFrEF treatment.
Uwe Zeymer, Andrew L. Clark, Vivencio Barrios, Thibaud Damy, Jarosław Dróżdż, Cândida Fonseca, Lars H. Lund, Stefanie Kalus, Philippe Ferber, Rizwan I. Hussain, C Koch, Aldo Maggioni
Uwe Zeymer, Andrew L. Clark, Vivencio Barrios, Thibaud Damy, Jarosław Dróżdż, Cândida Fonseca, Lars H. Lund, Gabriele Di Comite, Stephan Hupfer, Aldo Maggioni
Discussion(0)
No comments yet. Be the first to comment.